PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Yicheng Ni Selected Research
Necrosis
04/2008
Exploration of the mechanism underlying the tumor necrosis avidity of hypericin.
11/2007
Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
08/2005
Necrosis avid contrast agents: functional similarity versus structural diversity.
11/2002
Occlusive myocardial infarction enhanced or not enhanced with necrosis-avid contrast agents at MR imaging.
08/2002
Exploring multifunctional features of necrosis avid contrast agents.
05/2002
Necrosis-avid contrast agents: introducing nonporphyrin species.
Articles by Research Topic
Disease
6
Necrosis
04/2008 - 05/2002
4
Neoplasms (Cancer)
04/2008 - 09/2003
3
Myocardial Infarction
03/2007 - 02/2002
2
Stroke (Strokes)
08/2007 - 10/2004
1
Residual Neoplasm
11/2005
Drug/Important Bio-Agent (IBA)
5
Contrast Media
IBA
11/2005 - 05/2002
4
hypericin
IBA
04/2008 - 09/2003
2
microplasmin
IBA
08/2007 - 10/2004
1
Ethanol (Ethyl Alcohol)
IBA
01/2008
1
pamoic acid
IBA
11/2007
1
Tissue Plasminogen Activator (Alteplase)
FDA Link
08/2007
1
ECIII-60
IBA
03/2007
1
Gadolinium DTPA (Magnevist)
FDA Link
03/2007
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
09/2003
1
gadolinium mesoporphyrin
IBA
02/2002
Therapy/Procedure
1
Photochemotherapy (Photodynamic Therapy)
09/2003